Cardlytics Inc (NASDAQ:CDLX) insider Kirk Somers sold 2,591 shares of the company’s stock in a transaction that occurred on Thursday, March 21st. The stock was sold at an average price of $15.67, for a total transaction of $40,600.97. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

CDLX traded up $0.13 during trading on Thursday, hitting $16.13. 124,100 shares of the company’s stock were exchanged, compared to its average volume of 203,231. The company has a quick ratio of 2.40, a current ratio of 2.40 and a debt-to-equity ratio of 0.90. Cardlytics Inc has a 1 year low of $9.80 and a 1 year high of $28.29. The company has a market cap of $330.09 million and a P/E ratio of -7.54.

Cardlytics (NASDAQ:CDLX) last released its quarterly earnings data on Tuesday, March 5th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.43) by $0.37. Cardlytics had a negative net margin of 35.20% and a negative return on equity of 92.07%. Research analysts anticipate that Cardlytics Inc will post -1.88 earnings per share for the current year.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. grew its stake in Cardlytics by 0.4% during the fourth quarter. BlackRock Inc. now owns 422,718 shares of the company’s stock worth $4,578,000 after buying an additional 1,610 shares during the period. Bank of America Corp DE grew its stake in Cardlytics by 0.9% during the fourth quarter. Bank of America Corp DE now owns 270,025 shares of the company’s stock worth $2,924,000 after buying an additional 2,471 shares during the period. Wells Fargo & Company MN grew its stake in Cardlytics by 72.4% during the third quarter. Wells Fargo & Company MN now owns 8,004 shares of the company’s stock worth $201,000 after buying an additional 3,361 shares during the period. Bank of New York Mellon Corp grew its stake in Cardlytics by 22.3% during the third quarter. Bank of New York Mellon Corp now owns 19,029 shares of the company’s stock worth $477,000 after buying an additional 3,476 shares during the period. Finally, New York State Common Retirement Fund grew its stake in Cardlytics by 80.0% during the fourth quarter. New York State Common Retirement Fund now owns 9,000 shares of the company’s stock worth $97,000 after buying an additional 4,000 shares during the period. Institutional investors own 80.89% of the company’s stock.

Several brokerages recently commented on CDLX. Zacks Investment Research raised shares of Cardlytics from a “hold” rating to a “buy” rating and set a $21.00 price target for the company in a research report on Wednesday, March 6th. SunTrust Banks reaffirmed a “buy” rating and set a $25.00 price target on shares of Cardlytics in a research report on Wednesday, March 6th. Finally, Bank of America raised shares of Cardlytics from a “neutral” rating to a “buy” rating and set a $15.00 price target for the company in a research report on Tuesday, January 15th. One equities research analyst has rated the stock with a sell rating and seven have issued a buy rating to the company’s stock. Cardlytics presently has an average rating of “Buy” and an average target price of $22.86.

TRADEMARK VIOLATION NOTICE: This article was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another website, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this article can be viewed at https://www.thecerbatgem.com/2019/03/21/cardlytics-inc-cdlx-insider-kirk-somers-sells-2591-shares.html.

About Cardlytics

Cardlytics, Inc operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels.

Read More: What is the QQQ ETF?

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.